IceCure Medical Ltd. (NASDAQ: ICCM)
$0.76
+0.0101 ( +1.35% ) 124.8K
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Market Data
Open
$0.76
Previous close
$0.75
Volume
124.8K
Market cap
$36.39M
Day range
$0.75 - $0.77
52 week range
$0.52 - $1.57
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 6 | Jul 16, 2024 |
6-k | Quarterly Reports | 2 | Jul 09, 2024 |
6-k | Quarterly Reports | 2 | Jul 01, 2024 |
6-k | Quarterly Reports | 2 | Jun 04, 2024 |
6-k | Quarterly Reports | 2 | May 28, 2024 |
6-k | Quarterly Reports | 1 | May 21, 2024 |
6-k | Quarterly Reports | 2 | May 07, 2024 |
6-k | Quarterly Reports | 7 | Apr 15, 2024 |
6-k | Quarterly Reports | 2 | Apr 15, 2024 |
20-f | Annual reports | 97 | Apr 03, 2024 |